What Makes Pharmaceutical Mass Tort Litigation So Complex?

Mass torts involving prescription drugs are much more complex than many other types of litigation, such as single-event personal injury cases. Here are some of the main reasons why:

Longer Timeline

This type of litigation often lasts years. As time passes, the legal landscape can change and research about the effects of the drug can evolve. This can create challenges for plaintiffs and defendants.

Medications could stay on the market for years before researchers identify common problems experienced by consumers.

New studies, reports from patients and information uncovered during discovery could reveal information that changes public understanding of whether a medication is safe. For example, Risperdal was on the market for more than 10 years before the risk of gynecomastia became widely known. (In mid-2026, attorneys began investigating new Risperdal lawsuits.)

Examples of medical research and other information that could change public understanding of a medication include:

Epidemiological studies
Clinical trial data
Adverse event reports
Peer-reviewed medical literature
FDA communications

Discovery Can Take Quite a While

This is true for just about any type of mass tort, including cases involving defective or dangerous drugs. Plaintiff attorneys need to comb through medical records, medical research and documents from the corporations involved in producing the drug in question. Corporate documents may include:

Internal emails
Marketing materials
Clinical trial communications
Safety analyses
Regulatory correspondence
Research data
Executive discussions regarding risk management

Plaintiff attorneys often argue these materials demonstrate a company knew more about potential dangers than it told the public.

Reviewing and analyzing millions of pages of corporate documents can take years. It also requires significant resources.

Establishing Causation is Complicated

In a mass tort case, establishing a causal link between the actions of the defendant and the injuries suffered by the plaintiff is easier said than done. Single-event personal injury cases are typically about one event on a specific date. However, drug injury cases raise a series of more complex questions:

Were the plaintiff’s injuries directly caused by the medication?
Was the manufacturer aware of the dangers of the medication?
Were doctors and consumers adequately warned of the risks?
What was the role of scientific research in uncovering the dangers of the medication?
Were regulatory agencies notified of the danger?
Are there other medications or medical issues that may have contributed to the plaintiff’s injuries?

Plaintiff attorneys often need to turn to medical experts who have knowledge of various scientific disciplines. These experts often comment on issues like:

Whether warnings about the drug’s dangers were adequate
How the drug caused injuries
Drug mechanisms
Biological pathways
Statistical risks of the medication
Industry standards

The attorneys themselves also need to have detailed understanding of what to look for in medical evidence.

Another factor that adds to the complexity is the potential for long legal battles over which experts may testify and what scientific methodologies are considered acceptable. Both sides often present scientific interpretations that are at odds with each other.

Cases Often Involve More Than One Plaintiff

These cases are called mass torts because they often impact a lot of people who were affected by some sort of negligent action. In a mass tort drug case, these individuals suffered the same or similar injuries because of the same pharmaceutical product. Attorneys for the plaintiffs must manage the interests of a large group of people, which comes with its own set of challenges.

Multiple Defendants

While there is more than one plaintiff, there is usually more than one defendant in these cases. This could include distributors, manufacturers or other parties elsewhere in the supply chain. Pharmacies or doctors could even be held liable.

Plaintiff attorneys not only need to identify these parties, they must also determine their amount of liability.

New Legal Issues and Interpretations

Attorneys need to constantly stay informed about new developments and legal precedents to effectively pursue justice for their clients.

Coordinating Cases Across Jurisdictions

Mass torts often involve plaintiffs in different jurisdictions, which makes it challenging to coordinate these cases. This is especially true when mass torts are consolidated into multidistrict litigations (MDL) or class actions.

An MDL consolidates similar federal lawsuits before one judge for pretrial proceedings. The advantage of an MDL is that similar cases can be managed more efficiently. That said, MDLs can make things more complicated because:

Thousands of plaintiffs are involved
Multiple law firms may be involved
Extensive discovery disputes
Corporate document reviews
Coordinated expert testimony
Bellwether trials used to evaluate litigation trends

While MDLs help streamline portions of litigation, they can still take years to resolve due to the enormous amount of evidence involved.

Significant Damages

Mass torts can have substantial financial implications for both sides, as plaintiff attorneys are often pursuing significant compensation and liable parties can face serious financial consequences if they are found to have acted negligently.

Media Attention

These cases often attract a lot of attention from the public and the media. It is incumbent on plaintiff attorneys to carefully manage the public relations aspects of these cases. Statements to the media can have a positive or negative effect on the outcome of mass tort litigation.

The Impact of Mass Torts

Mass tort cases about prescription drugs have had significant influence on pharmaceutical regulation, public health policy and consumers. These are some of the most significant examples:

Talcum Powder Litigation: There were numerous claims against Johnson & Johnson about talcum powder products causing consumers to develop ovarian cancer. These cases resulted in huge verdicts against Johnson & Johnson and the company eventually stopped selling talc-based baby powder in North America.
Depakote Litigation: This is a drug that was used by patients suffering from bipolar disorder or seizures. Research uncovered a link to birth defects when taken by pregnant women. This led to numerous lawsuits claiming the manufacturer failed to warn about the risks.
Zantac Litigation: These cases claimed Zantac may contain or did contain N-Nitrosodimethylamine, which is likely a cancer-causing chemical. This resulted in significant recalls and additional scrutiny about testing of pharmaceuticals, storage and the risk of contamination.

Frequently Asked Questions

What is a pharmaceutical mass tort?

A pharmaceutical mass tort is a type of civil litigation involving numerous individuals who allege they suffered similar injuries from the same medication or pharmaceutical product. While plaintiffs’ claims are grouped together for portions of the litigation process, each person’s case remains individually evaluated based on their injuries and damages.

How are pharmaceutical mass torts different from class actions?

In a class action, one lawsuit generally represents an entire group of plaintiffs collectively. In a mass tort, each plaintiff maintains an individual claim, even though cases may be consolidated during pretrial proceedings through multidistrict litigation (MDL).

Can a pharmaceutical company still face lawsuits if the FDA approved the drug?

Yes. FDA approval does not automatically shield pharmaceutical manufacturers from liability. Lawsuits may still allege that a company failed to adequately warn consumers, misrepresented risks, or failed to update safety information as new evidence became available.

What role do expert witnesses play in pharmaceutical mass tort cases?

Expert witnesses often help explain complicated medical and scientific issues to courts and juries. These experts may include physicians, toxicologists, epidemiologists, pharmacologists, and regulatory specialists who analyze whether a medication could have contributed to a plaintiff’s injuries.

Why do pharmaceutical mass tort cases often take years to resolve?

These cases are highly complex and may involve thousands of plaintiffs, extensive scientific evidence, corporate discovery, expert testimony, and procedural issues within multidistrict litigation. Courts must carefully evaluate both scientific and legal arguments before cases can move toward resolution.